Company profile
Tasca Therapeutics
Leveraging our unique platform to exploit lipid-binding pockets on proteins to develop new medicines against cancer.
- Industry
- Biotechnology Research
- Employees
- 22
- Headquarters
- Cambridge, Massachusetts
- Founded
- 2021
- LinkedIn followers
- 892
- Office locations
- 1
Tasca Therapeutics company summary
Tasca Therapeutics is a company in the Biotechnology Research industry, headquartered in Cambridge, Massachusetts, founded in 2021. On LinkedIn the company has around 22 employees and 892 followers.
What technology does Tasca Therapeutics use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Tasca Therapeutics
By harnessing the power of mass spectrometry-based proteomics to identify cancer-causing proteins that undergo a specific post-translational modification called auto-palmitoylation, Tasca is uniquely positioned to utilize previously unknown binding pockets to develop novel therapies for difficult-to-treat cancers. Tasca’s lead program, CP-383, is being developed to treat patients with tumors harboring a specific genetic profile and is expected to enter clinical trials in 2025.
Where is Tasca Therapeutics located?
Tasca Therapeutics lists 1 location.
Compare companies similar to Tasca Therapeutics
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Tasca Therapeutics tascatx.com | Biotechnology Research | 22 | 2021 | Cambridge, Massachusetts |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Tasca Therapeutics
What does Tasca Therapeutics do?
By harnessing the power of mass spectrometry-based proteomics to identify cancer-causing proteins that undergo a specific post-translational modification called auto-palmitoylation, Tasca is uniquely positioned to utilize previously unknown binding pockets to develop novel therapies for difficult-to-treat cancers. Tasca’s lead program, CP-383, is being developed to treat patients with tumors harboring a specific genetic profile and is expected to enter clinical trials in 2025.
How many employees does Tasca Therapeutics have?
Tasca Therapeutics has around 22 employees on LinkedIn.
Where is Tasca Therapeutics headquartered?
Tasca Therapeutics is headquartered in Cambridge, Massachusetts.
When was Tasca Therapeutics founded?
Tasca Therapeutics was founded in 2021.
Build a lead list from companies like Tasca Therapeutics
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.